• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

Comprehensive Analysis of (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol (CAS No. 2227680-24-0)

The compound (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol (CAS No. 2227680-24-0) is a chiral amino alcohol derivative with significant potential in pharmaceutical and chemical research. Its unique structure, featuring a fluoro and nitro substituent on the aromatic ring, makes it a valuable intermediate in the synthesis of bioactive molecules. Researchers are increasingly interested in this compound due to its potential applications in drug discovery, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors.

One of the most searched questions in scientific databases is: "What are the synthetic routes for (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol?" This reflects the growing demand for efficient and scalable synthesis methods. The compound can be prepared via asymmetric reduction of the corresponding ketone or through resolution techniques. Recent advancements in catalytic asymmetric synthesis have improved the yield and enantiomeric purity of this compound, making it more accessible for research purposes.

The pharmacological properties of (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol are another hot topic among researchers. Its structural features suggest potential interactions with G-protein coupled receptors (GPCRs) and neurotransmitter transporters. These properties align with current trends in precision medicine and targeted drug delivery, which are highly searched keywords in the pharmaceutical community. The compound's chirality is particularly important, as enantiopure drugs often exhibit superior efficacy and safety profiles.

From a chemical stability perspective, the presence of both electron-withdrawing (nitro and fluoro) and electron-donating (amino and hydroxyl) groups creates interesting reactivity patterns. This duality makes the compound a subject of study in structure-activity relationship (SAR) analyses, a frequently searched term in medicinal chemistry circles. The nitrophenyl moiety, in particular, offers opportunities for further functionalization, which is valuable in combinatorial chemistry approaches.

In the context of green chemistry - a trending topic in scientific discussions - researchers are exploring eco-friendly purification methods for (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol. Techniques like supercritical fluid chromatography and aqueous workup procedures are gaining attention as alternatives to traditional organic solvent-based methods. These approaches address the increasing demand for sustainable chemical processes in pharmaceutical manufacturing.

The compound's spectroscopic characterization is another area of interest, with many researchers searching for detailed NMR and mass spectrometry data. The fluoro substituent provides a useful ¹⁹F NMR handle for reaction monitoring, while the nitro group offers distinctive IR absorption patterns. These features make the compound particularly amenable to analytical method development, another hot topic in chemical research.

Looking at computational chemistry applications - a rapidly growing field - (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol serves as an excellent model compound for studying molecular docking and quantum mechanical calculations. The presence of multiple functional groups allows for diverse interaction patterns with biological targets, making it valuable for in silico drug design studies. This aligns with current interests in AI-assisted drug discovery, one of the most searched topics in pharmaceutical research today.

In conclusion, (1R)-3-amino-1-(3-fluoro-4-nitrophenyl)propan-1-ol (CAS No. 2227680-24-0) represents a multifaceted compound with broad research applications. Its relevance to current scientific trends - from asymmetric synthesis to computational drug design - ensures continued interest from both academic and industrial researchers. As synthetic methodologies advance and biological evaluations progress, this compound is likely to play an increasingly important role in the development of novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)